{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-151705","form_type":"8-K","ticker":"TYRA","cik":"0001863127","company_name":"Tyra Biosciences, Inc.","filed_at":"2024-05-31T23:59:59+00:00","discovered_at":"2026-05-14T18:03:20.960374+00:00","generated_at":"2026-06-01T07:15:12.705091+00:00","sec_items":["3.03","5.03","5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Tyra Biosciences shareholders approve officer exculpation amendment to charter","bullets":["Amendment eliminates personal liability of officers for monetary damages for breach of fiduciary duty under Delaware law.","Three Class III directors elected: Melissa McCracken, Jake Simson, Rehan Verjee.","Ratification of Ernst & Young as independent auditor for fiscal year ending December 31, 2024.","Amendment effective upon filing with Delaware Secretary of State on May 29, 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-151705","json":"https://secwatch.observer/filing/0001193125-24-151705.json","markdown":"https://secwatch.observer/filing/0001193125-24-151705.md","text":"https://secwatch.observer/filing/0001193125-24-151705.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1863127/000119312524151705/0001193125-24-151705-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1863127/000119312524151705/d807421d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T07:15:12.705091+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}